Dr Paula Fujiwara, Chair of Stop TB Partnership's Global Plan to End TB Task Force 2023-2030 presents at AIDS 2022 in a third-party press conference hosted by Asia Pacific Cities Alliance for Health and Development (APCAT) and APCAT Media (Asia Pacific Media Alliance for Health and Development) and CNS. Thanks CNS team | www.citizen-news.org

1. Global Plan to End TB 2023-2030
Paula I. Fujiwara, Chair, Task Force of the Global Plan to End TB 2023-2030
Scientific Advisor, Asia Pacific Cities Alliance for Health and Development (APCAT)
24th International AIDS Conference (AIDS 2022), Montreal Canada
August 1, 2022

2. Outline
• What is the Global Plan to End TB, 2023-2030?
• What’s New
• Resource Needs
• Global Plan Impact and Priority Actions, 2023-2030
• Addressing Key and Vulnerable Populations (KVP)
• How to Promote Global and Country-level Advocacy Plans

3. What is the Global Plan to End TB, 2023-2030?
• Costed advocacy plan for TB
• Developed collaboratively (Task Force, regional consultations, surveys)
• 6th iteration; required for UN HLM on TB, 2023
• Audience: NTPs, NAPS, donors, community, private sector, activists,
researchers, etc)
• Living document

4. What’s new and the basis for advocacy
• People-centred, including all who affected by TB
• Subclinical TB
• One Health and zoonotic TB
• TB at center of pandemic preparedness response (PPR)
• Mental health
• Post-TB life
• Airborne prevention and control
• TB vaccine
• “Return on investment” and "cost of inaction"
• Research, research, research for new diagnostics, medications, vaccines
• Bidirectional communication between community and researchers

5. Global Plan Resource Needs, 2023-2030

6. TB gives value for money

7. Resources Needed to End TB, 2023-2030

8. Vaccine Costs are new

9. Global Plan Impact and Priority Actions, 2023-2030

10. Projected Impact by 2030
• ≥95% diagnosed
• High-risk, key & vulnerable pops (HIV)
periodically screened
• 50M access tx
• 3.7M children
• 2.2M with DR-TB
• 35M access TPT (HIV)
• ≥1 TB vaccine for widespread use by 2026
Compared to 2015 baseline:
• 80% decline/100 000 pop
• 90% decline in deaths

11. Addressing Key and Vulnerable Populations

12. KVP include:
• Increased exposure due to living or working situation
• prisoners, sex workers, HCWs, community health workers
• Limited access to quality TB services
• migrant workers, women in settings with gender disparity, children, refugees, IDP,
undocumented migrants, LGBTQ
• Increased risk of TB due to biologic or behavioral factors that compromise
immune function
• PLHIV, DM, silicosis, undernourished, use tobacco, alcohol use disorder, drug users)

13. Prioritize, reach, involve key and vulnerable populations (KVP)
• Convenient access to TB prevention and care
• primary care and integrated health services (e.g., nutritional support, TB-HIV, TB-
diabetes, TB and tobacco cessation);
• Understand social, political, legal and economic barriers of KVP
• Prioritize KVP as stakeholders and equal partners
• coordinate and collaborate with programmes, ministries focused on gender,
rights and development

14. Global Plan Priority Actions - 1
Chapter Key Priority Actions Advocacy Opportunity
1. Introduction n/a SDGs, 2023 HLM, G20
2. Needs to reach targets Comprehensive interventions, scale up
to meet targets
Country-level needs; establish new
targets at 2023 UNHLM
3. TB Care People-centred care: Early dx
(subclinical); screen w/ other health
risks; avoid catastrophic costs;
strengthen procurement/supply chains
Re-imagine TB care
4. TB Prevention Address underlying risk factors; TPT;
AIPC; new vaccines
Global focus on airborne disease
prevention; prep for new vaccines
5. Stakeholders: communities, private
sector
Increased $$ for communities;
community/home-based models; PPM;
partnerships
Mobilize communities; decentralize TB
services; new partners

15. Global Plan Priority Actions - 2
Chapter Key Priority Actions Advocacy Opportunity
6. PPR, UHC, Socioeconomic Actions Expand access through UHC efforts; TB
at center of PPR, poverty alleviation
Link w/ SDGs, mobilize via other
development & health security efforts
7. KVP, gender, stigma Human rights; eliminate TB stigma and
discrimination; gender responsive;
reduce stigma; reach KVP
Rights- and justice-based response
8. R&D for new tools accelerate R&D, deliver new tools;
create R&D enabling environment;
engage communities; ensure access;
strengthen new tools advocacy
Mobilize resources by bridging gap
between R&D and advocacy
communities;
new funding sources for TB R&D
9. Resources needed; ROI Mobilize US$209.9B for dx, care,
support, US$40B.2 for R&D; diversify
funding base; strengthen global
advocacy and comms
Achieve $40:$1 ROI; avoid massive cost
of inaction

16. How to Promote Global and
Country-level TB Advocacy Plans

17. Promoting Global and Country-level Advocacy Plans
• Country support and technical assistance
• Advocacy material/packages for resource mobilization
• UNHLM on TB 2023
• G20s with side meetings 2022-2024: Indonesia, India, Brazil
• 8 non-TB SDGs
• Global Fund Round 2023

18. Digital Report: a Living Document
https://omnibook.com/view/dc664b3a-14b4-4cc0-8042-ea8f27e902a6/en#panel-z-62ac